MARKET

CNTB

CNTB

Connect Biopharma Holdings Ltd
NASDAQ
0.8550
+0.0051
+0.60%
Opening 12:02 03/14 EDT
OPEN
0.8500
PREV CLOSE
0.8499
HIGH
0.8970
LOW
0.8500
VOLUME
7.25K
TURNOVER
--
52 WEEK HIGH
2.660
52 WEEK LOW
0.7654
MARKET CAP
47.24M
P/E (TTM)
6.21
1D
5D
1M
3M
1Y
5Y
1D
Connect Biopharma To Present At Leerink Partners Global Biopharma Conference; Webcast At 1:40 PM ET
NASDAQ · 2d ago
Weekly Report: what happened at CNTB last week (0303-0307)?
Weekly Report · 4d ago
Weekly Report: what happened at CNTB last week (0224-0228)?
Weekly Report · 03/03 12:05
Weekly Report: what happened at CNTB last week (0217-0221)?
Weekly Report · 02/24 12:05
Weekly Report: what happened at CNTB last week (0210-0214)?
Weekly Report · 02/17 12:01
Weekly Report: what happened at CNTB last week (0203-0207)?
Weekly Report · 02/10 11:54
Weekly Report: what happened at CNTB last week (0127-0131)?
Weekly Report · 02/03 12:00
Weekly Report: what happened at CNTB last week (0120-0124)?
Weekly Report · 01/27 12:04
More
About CNTB
More
Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company focused on improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research. It is building a pipeline of proprietary small molecules and antibodies, using functional T cell assays, to screen and discover potent product candidates against validated immune targets. Its lead product candidate, rademikibart, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα) in development for the treatment of atopic dermatitis (AD) and asthma. As an inhibitor of IL-4Rα, rademikibart blocks inflammatory signaling by both IL-4 and IL-13. Its second product candidate, icanbelimod, is a modulator of S1P1 T cell receptors and is in development for the treatment of ulcerative colitis (UC). Icanbelimod is an orally available, small molecule modulator of S1P1 that is designed to reduce inflammation without killing T cells.
Recently
Symbol
Price
%Change

Webull offers Connect Biopharma Holdings Ltd (ADR) stock information, including NASDAQ: CNTB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNTB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CNTB stock methods without spending real money on the virtual paper trading platform.